PFAS Testing Market Size, Share & Industry Analysis By Type (Products [Instruments {Liquid Chromatography Mass Spectrometry (LC-MS), Gas Chromatography Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance Spectroscopy & Others} and Consumables] and Software & Services), By Technique (Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS), Gas Chromatography-Mass Spectrometry (GC-MS), Mass Spectrometry & Others), By Application (Blood/Serum Testing, Microbial Testing, & Others), By End User, and Regional Forecast, 2026-2034

The global PFAS testing market size was valued at USD 377.8 million in 2025 and is projected to grow from USD 439.0 million in 2026 to USD 1,037.4 million by 2034, exhibiting a CAGR of 11.3% during the forecast period.

PFAS testing refers to laboratory analysis of samples such as water, blood, and other products to detect and confirm the presence of per and polyfluoroalkyl substances. The rising focus of governmental organizations toward stringent regulations is significantly augmenting the demand for PFAS testing, thereby supporting the adoption rate of testing products and services in the market.

• For instance, according to the 2025 statistics published by the American Chemical Society (ACS), it was reported that about seven target PFAS were detected in over 99% of human serum samples.

Furthermore, the growing health concerns associated with PFAS exposure and the expansion of environmental programs are also some other factors supporting the increasing demand for these products and services in the market. This, along with the growing focus of major players on research and development activities to develop and introduce novel products, including Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., and others, is expected to support the global PFAS testing market growth.

Market Dynamics

Market Drivers

Increasing Public Health Concerns Associated with PFAS Exposure to Drive Market Growth

The rising awareness of health risks linked with PFAS exposure is resulting in the growing penetration of PFAS testing across various applications, subsequently driving the growing adoption rate of these testing products in the market.

• For instance, according to the 2025 data published by the International Chemical Secretariat (ICS), it was reported that about 99% of all humans have measurable levels of PFAS in their bloodstreams.

PFAS chemicals have also been associated with a wide variety of health conditions such as thyroid disruption, immune dysfunction, and certain cancers. Increasing human exposure is resulting in growing public demand for stricter monitoring and transparency. Governmental and healthcare organizations are emphasizing routinely test for PFAS contamination to prevent long-term health consequences. Therefore, the factors mentioned above, along with the rising focus of prominent companies toward product launches, are anticipated to fuel the adoption rate, thereby supporting global PFAS testing market growth.

Other Prominent Drivers

• Escalating regulatory scrutiny and stricter drinking water/food/contact material limits are driving testing demand.
• Growing public, legal, and corporate interest in PFAS contamination and liability management, including litigation and remediation projects also drives the market growth.

Market Restraints

High Cost of PFAS Testing Products and Infrastructure to Limit Market Growth

There is an increasing demand for PFAS testing to detect and measure the presence of PFAS compounds. However, the high cost associated with these advanced instrumentation is anticipated to limit product adoption rate, especially in emerging nations such as Brazil, Mexico, and others.

PFAS testing requires advanced products such as liquid chromatography–tandem mass spectrometry (LC-MS/MS) or gas chromatography mass spectrometry (HRMS) coupled with specialized sample preparation workflows, sterile clean-lab environments, and skilled professionals, which substantially contribute to capital expenditure, operational costs, and maintenance needs.

• For instance, according to 2025 data published by Axion Analytical, Inc., it was reported that the price of a new gas chromatograph ranges from USD 30,000 to USD 100,000.

Therefore, high capital expenditure, less-developed healthcare infrastructure, and limited funding among prominent players are anticipated to limit the adoption rate of these products in the market.

Market Opportunities

Increasing Adoption in Developing Nations to Create Lucrative Opportunities

There is a growing health concerns associated with PFAS exposure, resulting in a growing focus on expanding PFAS-related regulations, especially in developing nations, including China, Brazil, and others. These countries are increasingly recognizing PFAS contamination as a public health and environmental threat, driving new testing regulations for drinking water, wastewater, and industrial contaminants. Increasing urbanization, growing healthcare expenditure, rising usage of chemicals in industries, and growing public awareness are further driving the demand for laboratory infrastructure, improved environmental monitoring, and compliance testing.

Moreover, growing awareness campaigns among governmental and healthcare organizations are some additional factors anticipated to fuel the product and software demand significantly during the forecast period.

• According to data published by Macrotends, the per capita healthcare spending was USD 672.45 in 2022, a 0.33% increase from 2021 in China.

Market Challenges

Lack of Standardized Methods for Testing to Limit Market Growth

There is a growing demand for innovative PFAS testing methods for various applications, such as water and soil testing across the globe. However, the lack of standard methods poses a major challenge for adoption of these products in the market.

The regulatory bodies have established certain methods for a limited set of PFAS compounds, including EPA Methods 533, 1633, and 537.1. However, these cover only a limited fraction of PFAS compounds currently identified. Hence, variations in analytical methods, sample preparation techniques, reporting limits, and target compound lists across regions such as the U.S., Europe, and others create inaccuracy in results, limit comparability, and further increase compliance complexity for industries.

• For instance, according to the 2025 study published by Rapid Micro Biosystems, Inc., it was reported that about 18% of respondents did not adopt rapid sterility testing owing to difficulties in regulatory acceptance among 66 respondents.

Therefore, the lack of standardized protocols makes it challenges for the prominent players to strengthen their product portfolio across various applications, thereby limiting product adoption rate in the market.

Other Prominent Challenges

• Backlogs and long turnaround times is a challenge as lab capacity struggles to keep pace with spikes in demand.
• Complexity of matrix interferences and need for validated methods for non‑water samples, such as food, cosmetics, and biological matrices deters market growth.

PFAS Testing Market Trends

Adoption of Advanced Methods to Fuel Product Demand

There is an increasing focus on the incorporation of technological advancements in analytical products in the market. The increasing adoption of high-resolution and advanced techniques such as mass spectrometry (HRMS) for non-target PFAS screening is reshaping the market. The regulatory requirements expand beyond a limited set of PFAS, resulting in growing demand toward HRMS technologies, such as time-of-flight (ToF) instruments and Orbitrap, to identify previously undetected or emerging PFAS levels in chemicals.

Moreover, technological advancement in these devices, such as integration of high‑throughput LC‑MS/MS platforms and automated sample prep to scale capacity and lower per‑sample costs, is further enhancing the development of methods, improving the robust compliance monitoring, thereby supporting the adoption of these products in the market.

• According to 2019 statistics published by Science Direct, it was reported that high-resolution mass spectrometry has discovered more than 750 PFAS compounds globally.

Other Prominent Trends

• Strong demand for accredited, certified PFAS testing services across environmental, food, cosmetics, and human biomonitoring samples.
• Increasing partnerships between instrument vendors and contract laboratories to deliver turnkey testing solutions.
• Consolidation and service expansion among major lab groups to capture remediation and corporate testing contracts.

Download Free sample to learn more about this report.

SEGMENTATION ANALYSIS

By Type

Increasing Product Launches to Drive Segmental Dominance

Based on type, the market is classified into products and software & services. The products segment is further classified into instruments and consumables. Instruments are further bifurcated into liquid chromatography mass spectrometry (LC-MS), gas chromatography mass spectrometry (GC-MS), nuclear magnetic resonance spectroscopy, and others.

To know how our report can help streamline your business, Speak to Analyst

The products segment held the largest market share in 2025. This growth is due to increasing health concerns associated with PFAS exposure, leading to a rise in diagnostic test volumes globally. This, along with the increasing focus of key players on research and development activities to launch novel devices, is further expected to support the segmental growth.

• In August 2025, Shimadzu Corporation launched the LCMS-8065XE triple quadrupole high-performance liquid chromatograph mass spectrometer in Japan and international markets.

The software & services segment is expected to grow at a CAGR of 11.6% over the forecast period. 

By Technique

Increasing Product Launches Led to the Dominance of the Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) Segment

Based on technique, the market is bifurcated into liquid chromatography with tandem mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS), mass spectrometry and others.

The liquid chromatography with tandem mass spectrometry (LC-MS/MS) segment dominated the market in 2025. In 2026, the segment is anticipated to dominate with a 59.6% share. This is due to increasing prevalence of infectious diseases, resulting in the rising demand for novel products in the market. This, along with rising focus among key players toward research and development activities to launch advanced PFAS testing products, is anticipated to support the segmental growth in the market.

• In June 2024, Thermo Fisher Scientific, Inc., launched a new mass spectrometry platform at the American Society for Mass Spectrometry (ASMS) conference.

The gas chromatography-mass spectrometry segment is expected to grow at a CAGR of 10.3% over the forecast period. 

By Application

The Growing Number of PFAS Testing Sites Led to Dominance of Water Testing Segment

Based on application, the market is segmented into blood/serum testing, microbial testing, water testing, and others.

The water testing segment dominated the global market in 2025. By application, the water testing segment held a largest share of 62.6% in 2025. This growth is due to increasing number of PFAS-contaminated sites, resulting in increasing demand for PFAS products and services, thereby contributing to the segment’s growth.

• For instance, according to 2025 statistics published by Environmental Working Group (EWG), there are about 9,552 PFAS-contaminated sites in the U.S.

The segment of blood/serum testing is set to grow with a growth rate of 12.2% across the forecast period.

By End-user

Increasing Initiatives Among Environmental Testing Laboratories Led to the Segment’s Dominance

Based on end user, the market is segmented into healthcare & research institutions, industrial & manufacturing companies, environmental testing laboratories, and others.

The environmental testing laboratories segment dominated the market in 2025. Increasing awareness about PFAS testing, growing healthcare expenditure, and growing initiatives to launch innovative methods among environmental testing laboratories are some of the vital factors contributing to segmental growth in the market. Furthermore, the segment is set to hold a 41.7% share in 2026.

• For instance, in September 2021, the EPA announced the first validated laboratory analytical method to test for 40 PFAS compounds in eight different environmental media: wastewater, surface water, groundwater, soil, biosolids, sediment, landfill leachate, and fish tissue.

In addition, healthcare & research institutions' end-users are projected to grow at a CAGR of 10.8% during the study period.

PFAS Testing Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held dominanting share in 2024, valued at USD 142.5 million, and also took the leading share in 2025 with USD 171.0 million. The dominance of the region is due to certain factors, including U.S. EPA regulatory activity, state‑level limits, extensive remediation testing demand, and growing establishment of PFAS treatment plants, among others. In 2026, the U.S. market is estimated to reach USD 178.6 million.

• For instance, in June 2025, Veolia established one of the largest PFAS treatment systems with an aim to strengthen its brand presence in the U.S.

Europe and Asia Pacific

Other regions, such as Europe and Asia Pacific, are expected to witness considerable CAGR during the forecast period. During the study period, the European region is projected to record a growth rate of 10.5% and reached the valuation of USD 106.0 million in 2025. This is due to wide PFAS restrictions and member states tightening drinking water limits, and growing lab investment in the region. Additionally, rising environmental monitoring programmes and increasing industrial testing demand are also some of the factors supporting the regional market growth. Backed by these factors, countries such as the U.K. are recorded the valuation of USD 11.5 million, Germany of USD 20.6 million, and France of USD 10.7 million in 2025. After Europe, the market in the Asia Pacific reached USD 78.9 million in 2025 and secure the position of the third-largest region in the market. In the region, India registed USD 9.9 million while China recorded USD 25.6 million in 2025.

Latin America and Middle East & Africa

Over the forecast period, the Latin America and Middle East & Africa regions are expected to witness moderate growth in this market. The Latin America market in 2025 recorded USD 12.1 million as its valuation. This growth is tied to regulatory adoption and investment in accredited lab capacity is anticipated to boost product adoption in these regions. In the Middle East & Africa, GCC is attained the value of USD 4.8 million in 2025.

Competitive Landscape

Key Industry Players

A Growing Number of Product Launches Among Players to Support Their Dominance

A diversified product portfolio of novel products, coupled with strong geographic presence globally, is one of the major factors contributing to dominance of these companies in the market. Thermo Fisher Scientific Inc., and Agilent Technologies, Inc., are major players in the market in 2025. Moreover, the rising focus of prominent players on research and development activities to launch novel products also supports the growing PFAS testing market share.

• For instance, in October 2025, Thermo Fisher Scientific, Inc., launched the Orbitrap Exploris EFOX system engineered specifically for food safety testing and environmental analysis.

Other key players, including Merck KGaA and others, are also growing in the market, primarily due to their increasing focus on product launches to strengthen their presence in the market.

List of Key PFAS Testing Companies Profiled

• Thermo Fisher Scientific Inc. (U.S.)
• Merck KGaA (Germany)
• Agilent Technologies, Inc. (U.S.)
• PerkinElmer (U.S.)
• Waters Corporation (U.S.)
• SGS Société Générale de Surveillance SA (Switzerland)
• Babcock Laboratories, Inc. (U.S.)
• Intertek Group plc (U.K.)
• Shimadzu Corporation (Japan)
• AccuStandard (U.S.)

KEY INDUSTRY DEVELOPMENTS

• October 2025 – The Wyoming Department of Environmental Quality (DEQ) announced a contract for no-cost monitoring of PFAS among public water systems. The testing is funded through Wyoming’s Emerging Contaminants in Drinking Water Grant and will help public water systems comply with the new U.S. EPA PFAS drinking water regulation.
• November 2024 – U.S. Environmental Protection Agency launched a new, no-cost technical assistance effort focused on reducing exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) and other emerging contaminants in small or disadvantaged communities. This helped the organization in strengthening its presence.
• June 2024 – Analytical Resource Labs (ARL), a provider of analytical testing services, launched its new PFAS testing service to strengthen its presence.
• June 2024 – Bigelow Laboratory for Ocean Sciences recently launched analytical services, certified by the State of Maine, to test for per- and polyfluoroalkyl substances, more commonly known as PFAS or “forever” chemicals.
• March 2024 – Waters Corporation announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS).

REPORT COVERAGE

The market report provides a detailed global PFAS testing market analysis and focuses on key aspects such as leading companies, type, technique, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation